Compare Flagstar Bank NA (FLG) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flagstar Bank NA vs ResMed Inc. — how do they compare? Flagstar Bank NA trades at $11.32 (market cap $4.71B), while ResMed Inc. trades at $230.05 (market cap $31.89B). The key difference: ResMed Inc. is far larger — about 6.8× Flagstar Bank NA's market cap, and ResMed Inc. pays the higher dividend (1.16%). Which is the better fit depends on your goals — on Pluang, investors hold Flagstar Bank NA for 22 Days and ResMed Inc. for 51 Days on average.
| FLG | RMD | |
|---|---|---|
Market Cap | $4.71B | $31.89B |
Volume | 7,410,589 | 618,314 |
Sector | Financials | Health |
52-Week High | $15.36 | $275.96 |
52-Week Low | $10.72 | $182.82 |
Typical Hold Time | 22 Days | 51 Days |
Enterprise Value | $15.25B | $31.24B |
Dividend Yield | 0.35% | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLG trades at $11.35, up 0.44% with a bearish technical signal despite recent earnings beats. The stock shows mixed fundamentals with a high P/E of 378.33 but trades below book value at P/B of 0.62. Recent Q2 2026 earnings missed expectations, though the company announced a $250 million share repurchase program and maintains a dividend. Analyst consensus remains bullish with a $17.07 price target.
FLG presents a turnaround opportunity with improving profitability from 2025 losses to 2026 projected net income of $48 million. Key risks include volatile cash flows and competitive banking pressures. The stock's discount to book value and strong analyst support suggest potential upside if execution improves.
ResMed (RMD) trades at $226.73, up 0.33% on the day, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming earnings report and positive analyst commentary on growth prospects.
The outlook is positive, driven by consistent earnings outperformance and a consensus price target of $242.70, implying upside. Key risks include competitive pressures and ongoing legal investigations. Institutional interest remains strong, with recent stake increases by funds. The stock's valuation metrics, such as a P/E of 21.74, appear reasonable given growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
